Differential modulation of P-glycoprotein expression by dexamethasone and 3-methylcholanthrene in rat hepatocyte primary cultures. 1994

E Chieli, and E Santoni-Rugiu, and F Cervelli, and A Sabbatini, and M Petrini, and N Romiti, and A Paolicchi, and R Tongiani
Dipartimento di Biomedicina Sperimentale, Università degli Studi di Pisa, Italy.

Spontaneous and culture condition-dependent changes in P-glycoprotein expression and activity have been monitored in primary cultures of rat hepatocytes by using immunoblotting, PCR and fluorimetric techniques. In hepatocytes cultured in basal medium without addition of dexamethasone or 3-methylcholanthrene, mdr mRNA and P-glycoprotein increased progressively throughout a 72 h culture period, in concert with an enhancement in the ability to extrude the fluorescent dye Rhodamine-123. Addition of 1 microM dexamethasone to the culture medium slowed down the increase in mdr mRNA and P-glycoprotein, while inducing a significant increase in the efficiency of R-123 efflux. Addition of either 100 nM or 10 microM DEX produced different changes in mdr mRNA and protein, unrelated to the rate of Rhodamine-123 extrusion. When 50 microM 3-methylcholanthrene was added to the culture medium in the absence of any hormone supplementation, no significant changes in P-glycoprotein activity and expression took place, in comparison with control cultures. On the contrary, in the presence of dexamethasone (100 nM and 1 microM), 3-methylcholanthrene induced an increase in mdr mRNA and in the amount of immunoblottable protein during culture, without producing any concomitant increase in the efficiency to extrude Rhodamine-123. The last phenomenon resulted to be an artefact, since 3-methylcholanthrene was shown to inhibit Rhodamine-123 transport competitively. These results indicate that rat hepatocyte P-glycoprotein may be variously modulated in vitro, by supplementing culture medium with hormones and/or xenobiotics. Functional activity of the P-glycoprotein is not necessarily related with protein amount and/or mdr RNA.

UI MeSH Term Description Entries
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008297 Male Males
D008562 Membrane Glycoproteins Glycoproteins found on the membrane or surface of cells. Cell Surface Glycoproteins,Surface Glycoproteins,Cell Surface Glycoprotein,Membrane Glycoprotein,Surface Glycoprotein,Glycoprotein, Cell Surface,Glycoprotein, Membrane,Glycoprotein, Surface,Glycoproteins, Cell Surface,Glycoproteins, Membrane,Glycoproteins, Surface,Surface Glycoprotein, Cell,Surface Glycoproteins, Cell
D008748 Methylcholanthrene A carcinogen that is often used in experimental cancer studies. 20-Methylcholanthrene,3-Methylcholanthrene,20 Methylcholanthrene,3 Methylcholanthrene
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D002352 Carrier Proteins Proteins that bind or transport specific substances in the blood, within the cell, or across cell membranes. Binding Proteins,Carrier Protein,Transport Protein,Transport Proteins,Binding Protein,Protein, Carrier,Proteins, Carrier
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D003907 Dexamethasone An anti-inflammatory 9-fluoro-glucocorticoid. Hexadecadrol,Decaject,Decaject-L.A.,Decameth,Decaspray,Dexasone,Dexpak,Hexadrol,Maxidex,Methylfluorprednisolone,Millicorten,Oradexon,Decaject L.A.
D004351 Drug Resistance Diminished or failed response of an organism, disease or tissue to the intended effectiveness of a chemical or drug. It should be differentiated from DRUG TOLERANCE which is the progressive diminution of the susceptibility of a human or animal to the effects of a drug, as a result of continued administration. Resistance, Drug
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

E Chieli, and E Santoni-Rugiu, and F Cervelli, and A Sabbatini, and M Petrini, and N Romiti, and A Paolicchi, and R Tongiani
February 1990, The Journal of biological chemistry,
E Chieli, and E Santoni-Rugiu, and F Cervelli, and A Sabbatini, and M Petrini, and N Romiti, and A Paolicchi, and R Tongiani
November 1993, Journal of cellular physiology,
E Chieli, and E Santoni-Rugiu, and F Cervelli, and A Sabbatini, and M Petrini, and N Romiti, and A Paolicchi, and R Tongiani
October 1995, Biochemical and biophysical research communications,
E Chieli, and E Santoni-Rugiu, and F Cervelli, and A Sabbatini, and M Petrini, and N Romiti, and A Paolicchi, and R Tongiani
September 1998, Journal of cellular physiology,
E Chieli, and E Santoni-Rugiu, and F Cervelli, and A Sabbatini, and M Petrini, and N Romiti, and A Paolicchi, and R Tongiani
June 1986, Cell biology and toxicology,
E Chieli, and E Santoni-Rugiu, and F Cervelli, and A Sabbatini, and M Petrini, and N Romiti, and A Paolicchi, and R Tongiani
October 2002, Journal of hepatology,
E Chieli, and E Santoni-Rugiu, and F Cervelli, and A Sabbatini, and M Petrini, and N Romiti, and A Paolicchi, and R Tongiani
August 1995, Biochemical and biophysical research communications,
E Chieli, and E Santoni-Rugiu, and F Cervelli, and A Sabbatini, and M Petrini, and N Romiti, and A Paolicchi, and R Tongiani
March 1984, Experimental cell research,
E Chieli, and E Santoni-Rugiu, and F Cervelli, and A Sabbatini, and M Petrini, and N Romiti, and A Paolicchi, and R Tongiani
July 1997, Cell biology and toxicology,
E Chieli, and E Santoni-Rugiu, and F Cervelli, and A Sabbatini, and M Petrini, and N Romiti, and A Paolicchi, and R Tongiani
September 1976, Science (New York, N.Y.),
Copied contents to your clipboard!